Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment

Neuroendocrine (NE) cancers arise from cells within the neuroendocrine system. Chemotherapies and endoradiotherapy have been developed, but their clinical efficacy is limited. The objective of this study was to develop a dual-targeted extracellular vesicles (EV)-delivered combined therapies to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Yingnan, Guan, JiaShiung, Xu, Yuanxin, Chen, Kai, Kim, Seulhee, Zhou, Lufang, Jaskula-Sztul, Renata, Liu, X. Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696983/
https://www.ncbi.nlm.nih.gov/pubmed/33187322
http://dx.doi.org/10.3390/pharmaceutics12111079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696983/
https://www.ncbi.nlm.nih.gov/pubmed/33187322
http://dx.doi.org/10.3390/pharmaceutics12111079

Ejemplares similares